September 2010

AIM: Clopidogrel plus PPI use is safe, large Danish study finds ()
TCT: Differences in outcomes of Cypher vs. PTCA still not CRISTAL clear ()
Circ: CARISMA reveals detailed insight into post-AMI arrhythmias ()
TCT: Self-expanding stents trump balloon-expanding stents in APPOSITION II ()
St. Jude names principal investigators for TAVI trial ()
AEM: Race, ethnicity may play role in ED decisions ()
JACC: Excessive oxygen use may worsen outcomes in cardiac patients ()
TCT: Patients covered by private payors are less likely to undergo PCI ()
ICD-10 Switch Requires Time, but Practices Lag in Planning ()
Lancet: CEA reduces stroke in those under 75; CAS benefits those under 70 ()
Stroke Imaging: Whats Best vs. Whats Practical ()
Timely Meaningful Use Adoption Could Reap Thousands of Dollars ()
First Word: Scary Trends ()
ACC Corner: New Survey Shows a Changing Practice Landscape ()
Circ: Widening statin use could be cost-effective, prevent CV events ()
HHS: Top pharma companies to offer 50% discount in 2011 ()
It's the repetition of affirmations that leads to belief. ()
Maquet launches trial to assess OPTIONs of EVH vs. CABG ()
Volcano fires back at St. Jude over patent lawsuit ()
Terumo launches guiding catheter for right radial access ()
Webinar: EHR certification stands on interoperability, standards ()
TCT: HORIZONS still looks good for DES, Angiomax; trial ends at 3 years ()
Hansen updates robotic catheter system ()
ACC to co-sponsor TCT 2011 ()
Q&A: Google-powered EMR-PHR integration ()
TCT: Polymer-free DES shows promise for safety at one year; larger studies to follow ()
TCT: Xience performs similarly to Cypher, not more EXCELLENT ()
TCT: Hospitals incur high clinical research costs, but they can be avoided ()
TCT: Weighing the risks and benefits of vascular closures ()
TCT: Peripheral DES trumps BMS and PTA in Zilver PTX trial ()
TCT: DES may have a role below the knee ()
TCT: What will design of the bioabsorbable stents look like? ()
TCT: SYNTAX investigators recommend PCI for most LM disease patients ()
TCT Video: RAPID MI-ICE trial show promise for pre-reperfusion hypothermia ()
TCT: ISAR-TEST fails to prove superiority of Xience over Cypher, but trends up ()
TCT: BIOrest LABR-312 may BLAST through as new anti-inflammatory therapy ()
TCT: No LEADERS emerge in biolimus/sirolimus stent debate ()
TCT: LANCELOT-ACS says certain doses of atopaxar can reduce bleeding, CV events ()
FDA approves U.S. PARTNER II trial for Edwards' next-gen valve ()
TCT Feature: Taxus Libert cant COMPARE with Xience V in all-comer trial ()
TCT Video: Sharifi aims to TORPEDO DVT via PEVI ()
Avandia stays in U.S. market with restrictions; EU seeks to shelve ()
TCT: TAVI is cost effective for elderly ()
TCT Feature: Bivalirudin's potential to save time, money explored ()
TCT: LEVANT I trial shows promise for drug-eluting balloons in fem-pop ()
TCT: PARTNER shines for TAVI method, long-term durability questions linger ()
TCT: Aortic stenosis has high prevelance, remains largely undertreated ()
TCT Feature: Prolonged bivalirudin decreases bleeds, adverse events during PCI ()
Sanofi reports disappointing results for angiogenic drug ()
TCT: Bivalirudin results in less costs, shorter hospital stays ()
TCT Video: Stone reveals two-year outcomes for SPIRIT IV ()
Standards drawn up for live case demos at meetings ()
TCT Video: Leon unveils PARTNER trial, speaks to benefits of TAVI ()
TCT Feature: Resolute performs well with diabetes, MVD in real-life registry ()
Companies merge microvolt T-wave technology with stress testing ()
FDA panel greenlights Boehringer's AF stroke prevention drug Pradaxa ()
FDA approves Medtronic's Integrity stent platform ()
BMC: Meta-analysis supports chest compressions before defibrillation ()
JAMA: Consultation+HF education does not reduce death, hospitalizations ()
Neovasc launches refractory angina trial in EU ()
FDA cautions about bladder cancer increase with long-term Actos use ()
NEJM: More evidence supports compression-only CPR by bystanders ()
Lilly, Transition Therapeutics kill diabetes drug development ()
FDA committee split on keeping Abbott's Meridia on market ()
FDA pushes off ticagrelor decision for three more months ()
SCAI issues curriculum for structural heart disease training ()
JACC: Brilinta trumps Plavix in antiplatelet effect in ACS patients ()
AIM: Lifestyle intervention for high-risk CV patients saves money ()
Avinger trials CTO crossing catheter to treat PAD ()
New FDA rule reclassifies PTCA catheters ()
Stroke: Mexican-Americans have higher rates of stroke recurrence ()
Edwards launches mitral valve device in U.S., Europe ()
Samaritan Heart adds valve specialist Ly to cardiac team ()
Circ: Gender may affect LV hypertrophy reversal after AV surgery ()
Medicines Company gets patent reprieve ()
U.S. heart centers join international therapeutic hypothermia effort ()
Lancet: Carotid stenting should be avoided in older patients ()
Toshiba highlights Infinix-i imaging system at TCT ()
JACC: ICD electrograms can identify VT in ablation patients ()
AtheroMed EASEs into PAD catheter trial ()
Study: Early use of heparin reduces risk of DVT by 43% ()
NEJM: CABG report cards show risks, but benefits may outweigh them ()
Radiology: Colon CAD improves reader sensivity even for small polyps ()
Accumetrics secures $7M in first round financing ()
NHLBI issues $11.6M grant to help diagnose HF among MI survivors ()
Radiology: Stand-alone colon CAD offers high sensitivity for screening ()
Feature: Doc, patient perceptions differ on PCI, consent needs overhaul ()
Stentys taps Piot as CFO ()
NEJM: Meridia worsens CV risks; FDA mulls its future ()
HRJ: CT can identify AF ablation patients at risk for esophageal injury ()
Feature: Expanded AAA screening algorithm targets 'missed' populations ()
ESC: Real-life AF management does little more than relieve symptoms ()
ESC: Upping Plavix dose meets with less stent thrombosis, more bleeds ()
N.C. card group gets rolled into WakeMed ()
HRJ: Demand for EPs rises due to procedural growth ()
ESC: Ivabradine cuts heart rate in HF patientsworthy of paradigm SHIFT? ()